false
OasisLMS
Catalog
Multiprofessional Critical Care Review: Pediatric ...
Vasoactive Agents and Support
Vasoactive Agents and Support
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Ryan Morgan's talk on vasoactive support highlighted the complexity and variability of inotrope use in ICUs. Inotropes improve myocardial and circulatory dysfunction by enhancing contractility and perfusion pressure, often acting through adrenergic receptors. Understanding the agents' effects—such as increasing heart rate (chronotropes), vascular resistance (vasoconstrictors), or promoting vasodilation (vasodilators)—is crucial. Dr. Morgan explained that inotropes rarely change preload but adjust contractility and heart rate to improve cardiac output. Mechanistically, they interact with receptors to alter calcium levels, affecting contractility and vasodilation. Specific agents like phenylephrine and isopropyl target particular receptors, while others like milrinone serve multiple roles. Understanding pressure-volume loops is critical for managing various cardiac conditions, including aortic stenosis and mitral regurgitation, as they illustrate the ventricular response to different hemodynamic states. The choice of vasoactive agents should be tailored to the patient's underlying condition and physiology.
Keywords
inotropes
vasoactive support
cardiac output
adrenergic receptors
pressure-volume loops
×
Please select your language
1
English